Cost-analysis of Implementing Robot-assisted Versus Open Pancreatoduodenectomy
J.E. Menso(Amsterdam University Medical Centers), Marc G. Besselink(Amsterdam Neuroscience), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Susan van Dieren(Amphia Ziekenhuis), Mahsoem Ali(Amsterdam Neuroscience), Jony van Hilst(OLVG), Olivier R. Busch(Amsterdam Neuroscience), Joris I. Erdmann(Amsterdam University Medical Centers), Gabriela Pilz da Cunha(Maastricht University Medical Centre), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Nine de Graaf(Fondazione Poliambulanza Istituto Ospedaliero), Michiel F.G. Francken(Amsterdam University Medical Centers), Barbara M. Zonderhuis(Amsterdam Neuroscience), Freek Daams(Maine Farmland Trust), Riccardo Guastella(University of Padua), Sebastiaan Festen(OLVG), Marcel G.W. Dijkgraaf(Amsterdam UMC Location University of Amsterdam), Alessandro Bonomi(University of Milan), H. Jaap Bonjer(Amsterdam University Medical Centers)
Cited by 3
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795